Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9517)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2017 (publication date) through Apr 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ju LL, Chen L, Li JH, Wang YF, Lu RJ, Bian ZL, Shao JG. Effect of NDC80 in human hepatocellular carcinoma. World J Gastroenterol 2017; 23(20): 3675-3683 [PMID: 28611520 DOI: 10.3748/wjg.v23.i20.3675] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i20/3675.htm |
| Number | Citing Articles |
| 1 |
Jing Li, Xiaoqin Xu, Xiting Peng. NDC80 Enhances Cisplatin-resistance in Triple-negative Breast Cancer. Archives of Medical Research 2022; 53(4): 378 doi: 10.1016/j.arcmed.2022.03.003
|
| 2 |
Rong Wei, Ziyue Wang, Yaping Zhang, Bin Wang, Ningning Shen, Li E, Xin Li, Lifang Shang, Yangwei Shang, Wenpeng Yan, Xiaoqin Zhang, Wenxia Ma, Chen Wang. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development. BMC Medical Genomics 2020; 13(1) doi: 10.1186/s12920-020-00762-5
|
| 3 |
Xin Yan, Chunfeng Liang, Xinghuan Liang, Li Li, Zhenxing Huang, Haiyan Yang, Yingfen Qin, Decheng Lu, Yan Ma, Zuojie Luo. The Screening and Identification of Key Biomarkers in Adrenocortical Carcinoma: Evidence from a Bioinformatics Analysis. Journal of Biomaterials and Tissue Engineering 2022; 12(3): 523 doi: 10.1166/jbt.2022.2834
|
| 4 |
Yun Ji, Yue Yin, Weizhen Zhang. Integrated Bioinformatic Analysis Identifies Networks and Promising Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma. International Journal of Genomics 2020; 2020: 1 doi: 10.1155/2020/2061024
|
| 5 |
Lu Zeng, Xiude Fan, Xiaoyun Wang, Huan Deng, Xiaoge Zhang, Kun Zhang, Shan He, Na Li, Qunying Han, Zhengwen Liu. Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma. BMC Medical Genomics 2020; 13(1) doi: 10.1186/s12920-020-00812-y
|
| 6 |
Lu Zeng , Xiude Fan , Xiaoyun Wang , Huan Deng , Kun Zhang , Xiaoge Zhang , Shan He , Na Li , Qunying Han , Zhengwen Liu. Bioinformatics Analysis based on Multiple Databases Identifies Hub Genes Associated with Hepatocellular Carcinoma. Current Genomics 2019; 20(5): 349 doi: 10.2174/1389202920666191011092410
|
| 7 |
Wei Jia, Qiaoling Wu, Ruipu Li, Shiyang Hou, Chunbo Kang. Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study. Medicine 2024; 103(18): e37984 doi: 10.1097/MD.0000000000037984
|
| 8 |
Yan-Li Hao, Zhao-Lian Bian, Lin-Ling Ju, Yuan Liu, Gang Qin. RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis. Digestive Diseases and Sciences 2020; 65(2): 470 doi: 10.1007/s10620-019-05758-5
|
| 9 |
Weijie Ye, Xisong Liang, Ge Chen, Qiao Chen, Hao Zhang, Nan Zhang, Yuanfei Huang, Quan Cheng, Xiaoping Chen. NDC80/HEC1 promotes macrophage polarization and predicts glioma prognosis via single‐cell RNA‐seq and in vitro experiment. CNS Neuroscience & Therapeutics 2024; 30(7) doi: 10.1111/cns.14850
|
| 10 |
Li-xin Liao, Meng Zhang, Xin Xu, Shan Zhang, Yu-zhen Guo. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression. Frontiers in Bioscience-Landmark 2024; 29(2) doi: 10.31083/j.fbl2902069
|
| 11 |
Shu Shen, Junjie Kong, Yiwen Qiu, Xianwei Yang, Wentao Wang, Lvnan Yan. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. Journal of Cellular Biochemistry 2019; 120(6): 10069 doi: 10.1002/jcb.28290
|
| 12 |
Harsha Motwani, Maulikkumar Patel, Nandan Dixit, Rakesh M. Rawal, Saumya K. Patel, Hitesh A. Solanki. Genome-scan meta-analysis identifies potential biomarkers for hepatitis B and hepatitis C virus-associated hepatocellular carcinomas. Human Gene 2023; 37: 201187 doi: 10.1016/j.humgen.2023.201187
|
| 13 |
Lishi Shao, Lei Liang, Qixiang Fang, Jiaping Wang. Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma. Heliyon 2022; 8(10): e10832 doi: 10.1016/j.heliyon.2022.e10832
|
| 14 |
Martin G. Klatt, Tao Dao, Zhiyuan Yang, Jianying Liu, Sung Soo Mun, Megan M. Dacek, Hanzhi Luo, Thomas J. Gardner, Christopher Bourne, Leila Peraro, Zita E. H. Aretz, Tanya Korontsvit, Michael Lau, Michael G. Kharas, Cheng Liu, David A. Scheinberg. A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies. Blood 2022; 140(8): 861 doi: 10.1182/blood.2021012882
|
| 15 |
Daniel Wai-Hung Ho, Yu-Man Tsui, Karen Man-Fong Sze, Lo-Kong Chan, Tan-To Cheung, Eva Lee, Pak-Chung Sham, Stephen Kwok-Wing Tsui, Terence Kin-Wah Lee, Irene Oi-Lin Ng. Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer. Cancer Letters 2019; 459: 176 doi: 10.1016/j.canlet.2019.06.002
|
| 16 |
Xia Chen, Ling Liao, Yuwei Li, Hengliu Huang, Qing Huang, Shaoli Deng, Fumio Imazeki. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus‐Associated Hepatocellular Carcinoma. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/7653506
|
| 17 |
Jianping Zeng, Shushan Hua, Jing Liu, Rajneesh Mungur, Yongsheng He, Jiugeng Feng. Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.928407
|
| 18 |
Shih-Hsien Chuang, Ying-Shuan E. Lee, Lynn Y.L. Huang, Chi-Kuan Chen, Chun-Liang Lai, Yu-Hsiang Lin, Ju-Ying Yang, Sheng-Chuan Yang, Lien-Hsiang Chang, Ching-Hui Chen, Chia-Wei Liu, Her-Sheng Lin, Yi-Ru Lee, Kuan Pin Huang, Kuo Chu Fu, Hsueh-Min Jen, Jun-Yu Lai, Pei-Shiou Jian, Yu-Chuan Wang, Wen-Yun Hsueh, Pei-Yi Tsai, Wan-Hua Hong, Chia-Chi Chang, Diana ZC. Wu, Jinn Wu, Meng-Hsin Chen, Kuo-Ming Yu, Ching Yuh Chern, Jia-Ming Chang, Johnson Y.N. Lau, Jiann-Jyh Huang. Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy. European Journal of Medicinal Chemistry 2020; 191: 112118 doi: 10.1016/j.ejmech.2020.112118
|
| 19 |
Lijie Zhang, Joyman Makamure, Dan Zhao, Yiming Liu, Xiaopeng Guo, Chuansheng Zheng, Bin Liang. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV‑associated hepatocellular carcinoma. Experimental and Therapeutic Medicine 2020; 20(1): 427 doi: 10.3892/etm.2020.8722
|
| 20 |
Mohib Ullah Kakar, Muhammad Zubair Mehboob, Muhammad Akram, Muddaser Shah, Yasmeen Shakir, Hafza Wajeeha Ijaz, Ubair Aziz, Zahid Ullah, Sajjad Ahmad, Sikandar Ali, Yongxiang Yin, Kun Li. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/4237633
|
| 21 |
Xuan Li, Hefen Sun, Qiqi Liu, Yang Liu, Yifeng Hou, Wei Jin. A pharmacophore‐based classification better predicts the outcomes of HER2‐negative breast cancer patients receiving the anthracycline‐ and/or taxane‐based neoadjuvant chemotherapy. Cancer Medicine 2021; 10(13): 4658 doi: 10.1002/cam4.4022
|
| 22 |
Jiayi Zhang, Zheng Zhang, Chenqing Yang, Qingguang Liu, Tao Song. Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-91475-1
|
| 23 |
Chengzhang Li, Jiucheng Xu. Feature selection with the Fisher score followed by the Maximal Clique Centrality algorithm can accurately identify the hub genes of hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53471-0
|
| 24 |
Jiamei Liu, Shengye Liu, Xianghong Yang. Construction of Gene Modules and Analysis of Prognostic Biomarkers for Cervical Cancer by Weighted Gene Co-Expression Network Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.542063
|
| 25 |
Zheng Wan, Xiaohong Zhang, Yuyang Luo, Bin Zhao. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses. Genetic Testing and Molecular Biomarkers 2019; 23(11): 766 doi: 10.1089/gtmb.2019.0063
|
| 26 |
Jia Wang, Rui Peng, Zheng Zhang, Yixi Zhang, Yuke Dai, Yan Sun, Zhenbo Xu. [Retracted] Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/6662114
|
| 27 |
Laner Shi, Xin Shang, Kechao Nie, Zhiqin Lin, Meisi Zheng, Miao Wang, Haoyu Yuan, Zhangzhi Zhu. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma. Journal of Clinical Pathology 2021; 74(8): 504 doi: 10.1136/jclinpath-2020-206979
|
| 28 |
Lianghai Wang, Lisha Zhou, Jun Hou, Jin Meng, Ke Lin, Xiangwei Wu, Xueling Chen. Three novel circRNAs upregulated in tissue and plasma from hepatocellular carcinoma patients and their regulatory network. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01762-w
|
| 29 |
Nandan Dixit, Maulikkumar Patel, Harsha Motwani, Saumya K. Patel, Rakesh M. Rawal, Hiteshkumar A. Solanki. Deciphering the latent biomarkers in HBV and HDV- associated HepatoCellular carcinoma – An integrated bioinformatics analysis. Human Gene 2024; 40: 201287 doi: 10.1016/j.humgen.2024.201287
|
| 30 |
Huan Yue, Kaifeng Wu, Kanglin Liu, Luxia Gou, Ailong Huang, Hua Tang. LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway. Cellular Oncology 2022; 45(3): 447 doi: 10.1007/s13402-022-00676-7
|
| 31 |
Cheng Hu, Weiming Lin, Kemeng Zhao, Guiyou Tian, Xiangquan Kong, Guangcheng Luo, Dieter A. Wolf, Yabin Cheng. NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma. iScience 2023; 26(4): 106531 doi: 10.1016/j.isci.2023.106531
|
| 32 |
Mohan Huang, Sijun Yang, William Chi Shing Tai, Lingfeng Zhang, Yinuo Zhou, William Chi Shing Cho, Lawrence Wing Chi Chan, Sze Chuen Cesar Wong. Bioinformatics Identification of Regulatory Genes and Mechanism Related to Hypoxia-Induced PD-L1 Inhibitor Resistance in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(10): 8720 doi: 10.3390/ijms24108720
|
| 33 |
Qisheng Su, Qinpei Ding, Zunni Zhang, Zheng Yang, Yuling Qiu, Xiaohong Li, Wuning Mo, Mario U. Manto. Identification of Genes Associated with the Metastasis of Pheochromocytoma/Paraganglioma Based on Weighted Gene Coexpression Network Analysis. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/3876834
|
| 34 |
Han Gao, Qing-yun Pan, Ying-ju Wang, Quan-fang Chen. Impact of KMN network genes on progression and prognosis of non-small cell lung cancer. Anti-Cancer Drugs 2022; 33(1): e398 doi: 10.1097/CAD.0000000000001220
|
| 35 |
Khaa Hoo Ong, Hong-Yue Lai, Ding-Ping Sun, Tzu-Ju Chen, Steven Kuan-Hua Huang, Yu-Feng Tian, Chia-Lin Chou, Yow-Ling Shiue, Ti-Chun Chan, Chien-Feng Li, Yu-Hsuan Kuo. Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01575-9
|
| 36 |
Sheng Zhong, Bo Wu, Xuechao Dong, Yujuan Han, Shanshan Jiang, Ying Zhang, Yang Bai, Sean X. Luo, Yong Chen, Huimao Zhang, Gang Zhao. Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug. World Neurosurgery 2018; 109: e329 doi: 10.1016/j.wneu.2017.09.176
|
| 37 |
Yi Liao, Guofang Yin, Xue Wang, Ping Zhong, Xianming Fan, Chengliang Huang. Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10685
|
| 38 |
Peng Zhang, Jiang-Hua Zhao, Liu-Xia Yuan, Lin-Ling Ju, Hui-Xuan Wang, Feng Wang, Lin Chen, Wei-Hua Cai. DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-43835-y
|
| 39 |
Yifan Wang, Linling Ju, Feng Xiao, Hui Liu, Xi Luo, Lin Chen, Zhonghua Lu, Zhaolian Bian. Downregulation of nucleolar and spindle‑associated protein 1 expression suppresses liver cancer cell function. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7314
|
| 40 |
Dongdong Chen, Zhijun Feng, Mingzhen Zhou, Zhijian Ren, Fan Zhang, Yumin Li, Rafael S. De Molon. Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular Carcinoma. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/4092635
|
| 41 |
Anyin Yang, Jianping Liu, Mengru Li, Hong Zhang, Xulei Zhang, Lianping Wu. Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma. Diagnostic Pathology 2024; 19(1) doi: 10.1186/s13000-024-01528-8
|
| 42 |
Pratik Singh, Mansi Patel, Doulat Bhowmik, Neha Kumari, Suresh Prajapati, Reeshu Gupta. Identification of common biomarkers affecting patient survival in cancers. World Academy of Sciences Journal 2024; 6(6) doi: 10.3892/wasj.2024.268
|